EUVIMEDEUVIMED entdecken
Crossref

Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder

Alysse G Wurcel, Daniel C DeSimone, Laura Marks, Larry M Baddour, Parham Sendi

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.04.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Alysse G Wurcel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, MA, USA; Tufts University School of Me…. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Substance-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocarditis, BacterialEndocarditisSubstance-Related DisordersHumansAnti-Bacterial AgentsGlycopeptides

Stichwörter der Autor:innen

EndocarditisOral antibioticsOritavancinPeople who inject drugs

Substanzen

Anti-Bacterial AgentsGlycopeptides

Autor:innen und Institutionen

  • Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, MA, USA; Tufts University School of Medicine, Boston, MA, USA.
  • Division of Public Health, Infectious Diseases and Occupational Medicine, Departments of Medicine and Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA.
  • Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
  • Institute for Infectious Diseases, University of Bern, Bern, Switzerland. Electronic address: parham.sendi@unibe.ch.

Förderung

  • AHRQ HHS

Zitieren

APA

Wurcel, A. G., DeSimone, D. C., Marks, L., Baddour, L. M., & Sendi, P. (2023). Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.04.005

Vancouver

Wurcel AG, DeSimone DC, Marks L, Baddour LM, Sendi P. Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.04.005

BibTeX
@article{Wurcel2023,
  author = {Wurcel, Alysse G and DeSimone, Daniel C and Marks, Laura and Baddour, Larry M and Sendi, Parham},
  title = {Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.04.005}
}
Kostenlos starten →